BTIG Research reiterated their buy rating on shares of Monopar Therapeutics (NASDAQ:MNPR – Free Report) in a research note published on Wednesday morning,Benzinga reports. BTIG Research currently has a $104.00 target price on the stock. A number of other equities research analysts have also commented on MNPR. Barclays set a $125.00 price target on shares […]

Palvella Therapeutics (NASDAQ:PVLA – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at BTIG Research in a research note issued on Friday,Benzinga reports. They presently have a $192.00 price target on the stock. BTIG Research’s target price would indicate a potential upside of 88.24% from the stock’s previous close. Other equities […]